1-6 of 6
Hong Zheng, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dasatinib Promotes the Maturation of Healthy Donors and Chronic Myelogenous Leukemia Patients Derived Dendritic Cells

Wangjun Cao, Lin He, Hong Zheng, MDPhD, Xiaobing Huang, Xi Yang, Xiaodong WANG, MD, Jingying Dai, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 53–54.
https://doi.org/10.1182/blood-2020-138462
Published: 2020
Journal Articles

Minimal Residual Disease (MRD) at Time of Complete Remission Is Commonly Detected in Acute Myeloid Leukemia (AML) Patients Age ≥60 Years and Significantly Impacts Outcome Based on Post-Remission Treatment Strategies: Prospective Analysis of ECOG-ACRIN (E-A) E2906 Phase III Trial

James M. Foran, MD, Zhuoxin Sun, PhD, Elisabeth Paietta, PhD, Janis Racevskis, PhD, David F. Claxton, MD, Hillard M Lazarus, MD, Daniel A. Arber, MD, Jacob M. Rowe, MD, Jessica K. Altman, MD, Aref Al-Kali, MD, Hong Zheng, MDPhD, Keith W. Pratz, MD, Edward R. Broun, MD, Bayard L. Powell, MD, Kristen Marie O'Dwyer, MD, John Godwin, MD, Yanming Zhang, MD, Martin S. Tallman, MD, Selina Luger, MD, Mark R. Litzow, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 437.
https://doi.org/10.1182/blood-2018-99-113950
Published: 2018
Journal Articles

Bone Marrow CD8 T Cells Express High Frequency of PD-1 and Exhibit Reduced Anti-Leukemia Response in AML Patients

Bei Jia, MD PhD, Liru Wang, David F. Claxton, W. Christopher Ehmann, Witold B. Rybka, Shin Mineishi, Hiroko Shike, Michael Bayerl, Todd D. Schell, Raymond J. Hohl, Hong Zheng, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3946.
https://doi.org/10.1182/blood.V130.Suppl_1.3946.3946
Published: 2017
Journal Articles

Mechanisms of GVL-Resistance: T Cell Exhaustion and a Failure of Antigen Cross-Presentation

Meng Zhou, Sarah Rosenberger, Kai Zhao, PhD, Hong Zheng, MDPhD, Warren D Shlomchik, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4461.
https://doi.org/10.1182/blood.V130.Suppl_1.4461.4461
Published: 2017
Journal Articles

Eomes + T-bet int CD8 T Cells Are Functionally Impaired and Associate with Primary Refractory Disease in Patients with Acute Myeloid Leukemia (AML)

Bei Jia, MD PhD, David F. Claxton, W. Christopher Ehmann, Witold B. Rybka, Shin Mineishi, Liru Wang, Todd D. Schell, Raymond J. Hohl, Hong Zheng, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 108.
https://doi.org/10.1182/blood.V130.Suppl_1.108.108
Published: 2017
Journal Articles

This Is a Title in Chidamide, a Novel HDAC Inhibitor, Is Effective for Treating Leukemia Relapse Post Allogeneic Stem Cell Transplantation and Results in Th1 Polarization in AML Patients with AML1-ETO

Xi Yang, Xiaobing Huang, MDand PhD, Hong Zheng, MDPhD, Chenglong Li, MDand PhD, Jingying Dai, PhD, Rong Zhang, MDand PhD, Xiaodong Wang, PhD, Chunsen Wang, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3278.
https://doi.org/10.1182/blood.V130.Suppl_1.3278.3278
Published: 2017